YOUR PARTNERS IN

Medical Affairs

Magnifying Science to Optimize Launch
and Improve Patient Outcomes

A Passionate Team of Medical Affairs Experts

28
Years In Medical Affairs

TMAC’s executive leadership team has been actively engaged in medical affairs for over 20 years.

217
Pharma, Biotech & Device Clients

TMAC supports clients from the largest top pharma, biotech & device companies to small start-ups launching their first products.

153
Product Launches

TMAC has supported pre-launch and launch activities for drugs & devices in numerous therapeutic areas.

4,000
Health Care Professionals Hired...and counting

TMAC has recruited & hired over 4,000 HCPs including Contract MSLs, Executives, Pharmacists, and Nurses.

16
Avg Years Experience Management Team

TMAC’s Directors and Managers are highly skilled in Medical Affairs & collaborating with clients for program success.

Comprehensive

Medical Affairs Solutions

On-the-ground medical affairs capabilities to take you from planning and development through commercialization, amplifying your investment and accelerating your path to success.

divider

Careers

MSLs • CTLs • VP Medical Affairs • Chief Medical Officer

"TMAC has provided me with an excellent environment to grow through roles of increasing responsibility. It has empowered me to succeed as a leader of medical science and clinical liaison teams, and to strive for opportunities to innovate and to build strong relationships within the industry."
<— Laura C. Luchetti, Ph.D.  Director, Field Medical Programs
<— Laura C. Luchetti, Ph.D.  Director, Field Medical Programs
— Laura C. Luchetti, Ph.D. Director, Field Medical Programs
Pre-Launch MSLs Invaluable to Treatment Adoption

The recently released Veeva Pulse Field Trend’s Report revealed clear findings that the utilization of field-medical liaisons pre-launch significantly impacts clinical practices’ adoption of a treatment by a 1.5- fold increase in the first 6-months post-launch compared to products not being supported with MSLs. Translating science into a commercially agreeable language early on is, without a doubt, critical.

Advancing healthcare one relationship at a time.